Stock code: 002653.SZ
Business News
Business News
Xinhua Net: Haisco Technology Steps into the Top Tier of Innovation
Jun 26, 2026
Learn more
Shareholders Arrive" - 2024 Investor Rights Protection Knowledge Contest Event
2024-05-23
Learn more
Resist illegal securities and futures fund activities, protect the legal rights of investors" — 2024 Illegal Securities and Futures Prevention Campaign Month
2024-05-21
Learn more
Haisco Innovation Drug HSK36357 Capsules: First Participant Enrolled in Phase I Clinical Trial
2023-12-12
Learn more
Haisco Innovation Drug HSK39775 tablets IND has been accepted.
2023-12-12
Learn more
Hisicor Pharmaceutical Group won the second prize in the “China (Xiaoshan) Biopharmaceutical Industry High-Value Patent Cultivation Competition”.
2023-12-01
Learn more
Heixike signed an authorization and licensing agreement for HSK31858 tablets with the Italian Chiesi Group
2023-11-22
Learn more
Hisicor Pharmaceutical Group was awarded the honorary title of “Best Industrial Enterprise for Pharmaceutical R&D Product Lines in China, 2023”.
2023-11-21
Learn more
Haisco Innovation drug HSK21542 tablets: First participant enrolled in Phase I clinical trial
2023-10-10
Learn more
Hisicuo launches the “Financial Consumer Rights Protection Education Campaign Month” activity
2023-09-28
Learn more
Haisco Group's Official WeChat Account
Haisco Investor Relations WeChat Account
Haisco Raw Materials Procurement Inquiries